Royal Bank of Canada’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2K | Buy |
1,189
+1,003
| +539% | +$2.43K | ﹤0.01% | 6772 |
|
|
2025
Q4 | $0 | Sell |
186
-2,569
| -93% | -$6.33K | ﹤0.01% | 7705 |
|
|
2025
Q3 | $8K | Buy |
2,755
+368
| +15% | +$1.09K | ﹤0.01% | 6584 |
|
|
2025
Q2 | $7K | Buy |
2,387
+299
| +14% | +$869 | ﹤0.01% | 6582 |
|
|
2025
Q1 | $6K | Sell |
2,088
-2,169
| -51% | -$7.48K | ﹤0.01% | 6322 |
|
|
2024
Q4 | $17K | Buy |
4,257
+1,819
| +75% | +$12.4K | ﹤0.01% | 6182 |
|
|
2024
Q3 | $20K | Buy |
2,438
+490
| +25% | +$3.22K | ﹤0.01% | 6116 |
|
|
2024
Q2 | $11K | Buy |
1,948
+1,849
| +1,868% | +$14.3K | ﹤0.01% | 6313 |
|
|
2024
Q1 | $1K | Sell |
99
-189
| -66% | -$1.08K | ﹤0.01% | 6882 |
|
|
2023
Q4 | $1K | Sell |
288
-1,147
| -80% | -$4.57K | ﹤0.01% | 7001 |
|
|
2023
Q3 | $6K | Sell |
1,435
-1,322
| -48% | -$6.62K | ﹤0.01% | 6587 |
|
|
2023
Q2 | $17K | Buy |
2,757
+304
| +12% | +$1.37K | ﹤0.01% | 6297 |
|
|
2023
Q1 | $8K | Buy |
2,453
+453
| +23% | +$1.69K | ﹤0.01% | 6427 |
|
|
2022
Q4 | $7K | Hold |
2,000
| – | – | ﹤0.01% | 6668 |
|
|
2022
Q3 | $7K | Hold |
2,000
| – | – | ﹤0.01% | 6620 |
|
|
2022
Q2 | $11K | Sell |
2,000
-936
| -32% | -$6.3K | ﹤0.01% | 6362 |
|
|
2022
Q1 | $25K | Sell |
2,936
-1,637
| -36% | -$16.4K | ﹤0.01% | 6489 |
|
|
2021
Q4 | $51K | Buy |
4,573
+1,298
| +40% | +$16.9K | ﹤0.01% | 6366 |
|
|
2021
Q3 | $43K | Buy |
3,275
+245
| +8% | +$3.9K | ﹤0.01% | 6250 |
|
|
2021
Q2 | $50K | Buy |
3,030
+364
| +14% | +$6.17K | ﹤0.01% | 6043 |
|
|
2021
Q1 | $45K | Buy |
2,666
+566
| +27% | +$10.6K | ﹤0.01% | 5960 |
|
|
2020
Q4 | $33K | Buy |
2,100
+100
| +5% | +$1.84K | ﹤0.01% | 5838 |
|
|
2020
Q3 | $38K | Hold |
2,000
| – | – | ﹤0.01% | 5466 |
|
|
2020
Q2 | $27K | Sell |
2,000
-185
| -8% | -$2.6K | ﹤0.01% | 5472 |
|
|
2020
Q1 | $23K | Sell |
2,185
-2,450
| -53% | -$39.9K | ﹤0.01% | 5484 |
|
|
2019
Q4 | $87K | Buy |
4,635
+2,587
| +126% | +$33.3K | ﹤0.01% | 5161 |
|
|
2019
Q3 | $22K | Buy |
2,048
+48
| +2% | +$391 | ﹤0.01% | 5476 |
|
|
2019
Q2 | $15K | Sell |
2,000
-1,537
| -43% | -$13.4K | ﹤0.01% | 5864 |
|
|
2019
Q1 | $39K | Buy |
3,537
+1,299
| +58% | +$10.5K | ﹤0.01% | 5309 |
|
|
2018
Q4 | $11K | Buy |
2,238
+38
| +2% | +$156 | ﹤0.01% | 5856 |
|
|
2018
Q3 | $7K | Sell |
2,200
-105
| -5% | -$409 | ﹤0.01% | 6133 |
|
|
2018
Q2 | $10K | Sell |
2,305
-2,587
| -53% | -$11.7K | ﹤0.01% | 5830 |
|
|
2018
Q1 | $26K | Buy |
4,892
+4,645
| +1,881% | +$21.4K | ﹤0.01% | 5354 |
|
|
2017
Q4 | $1K | Sell |
247
-1,796
| -88% | -$7.56K | ﹤0.01% | 6432 |
|
|
2017
Q3 | $9K | Buy |
2,043
+1,735
| +563% | +$8.19K | ﹤0.01% | 6302 |
|
|
2017
Q2 | $2K | Sell |
308
-831
| -73% | -$7.96K | ﹤0.01% | 6298 |
|
|
2017
Q1 | $18K | Sell |
1,139
-1,093
| -49% | -$14.3K | ﹤0.01% | 5684 |
|
|
2016
Q4 | $22K | Buy |
2,232
+2,032
| +1,016% | +$27K | ﹤0.01% | 5727 |
|
|
2016
Q3 | $3K | Hold |
200
| – | – | ﹤0.01% | 6108 |
|
|
2016
Q2 | $4K | Hold |
200
| – | – | ﹤0.01% | 6020 |
|
|
2016
Q1 | $2K | Sell |
200
-47
| -19% | -$389 | ﹤0.01% | 6147 |
|
|
2015
Q4 | $3K | Sell |
247
-148
| -37% | -$1.89K | ﹤0.01% | 6299 |
|
|
2015
Q3 | $6K | Sell |
395
-245
| -38% | -$4.29K | ﹤0.01% | 6110 |
|
|
2015
Q2 | $12K | Buy |
+640
| New | +$13.3K | ﹤0.01% | 5980 |
|
Other funds holding XBIT
VCM
RC
BCM
VFT
Royal Bank of Canada's XBIT Position: Q1 2026 in Review
Royal Bank of Canada increased its XBiotech (XBIT) stake by 539% in Q1 2026, buying an estimated $2.43K and bringing the position to 1,189 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #6772.
Royal Bank of Canada first reported a position in XBIT in Q2 2015 and has held it in 44 quarters since. The position peaked at $87K in Q4 2019. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.
- Royal Bank of Canada held 1,189 shares of XBiotech worth $2K as of Q1 2026.
- Royal Bank of Canada bought 1,003 XBiotech shares in Q1 2026, an estimated $2.43K.
- XBiotech made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6772 holding.
- Royal Bank of Canada first reported a position in XBiotech in Q2 2015 and has held it in 44 quarters since.
- Royal Bank of Canada's XBiotech position peaked at $87K in Q4 2019.
- 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.